Cynosure To Host Fourth-Quarter 2015 Financial Results Conference Call On February 9

Jan 26, 2016, 08:30 ET from Cynosure, Inc.

WESTFORD, Mass., Jan. 26, 2016 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today announced that the Company will release its fourth-quarter 2015 financial results before the market opens on Tuesday, February 9, 2016 and host a conference call for investors and analysts that day at 9:00 a.m. ET.

On the call, Chairman and Chief Executive Officer Michael Davin and President and Chief Financial Officer Timothy Baker will discuss Cynosure's financial results, as well as the Company's business outlook and strategy.

Those who wish to listen to the conference call webcast should visit the "Investors" section of the Company's website at www.cynosure.com.  The live call also can be accessed by dialing (877) 709-8155 or (201) 689-8881.  If you are unable to listen to the live call, the webcast will be archived on the Company's website.

About Cynosure, Inc.
Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to remove unwanted hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through non-invasive and minimally invasive laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve vaginal health. Cynosure also markets radiofrequency energy sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd:YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and radiofrequency technology.  Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries.  For corporate or product information, visit Cynosure's website at www.cynosure.com.

Contact
Scott Solomon
Senior Vice President
Sharon Merrill Associates
617-542-5300
cyno@investorrelations.com

 

SOURCE Cynosure, Inc.



RELATED LINKS

http://www.cynosure.com